1-4 of 4
Kathryn A. Mason
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells

Free
Kathleen A. Bridges, Hiroshi Hirai, Carolyn A. Buser, Colin Brooks, Huifeng Liu, Thomas A. Buchholz, Jessica M. Molkentine, Kathryn A. Mason, Raymond E. Meyn
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (17): 5638–5648.
https://doi.org/10.1158/1078-0432.CCR-11-0650
Published: 01 September 2011
View articletitled, MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
Open the PDF for MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells in another window
Includes: Supplementary data
Journal Articles

130-nm Albumin–Bound Paclitaxel Enhances Tumor Radiocurability and Therapeutic Gain

Free
Nicole Wiedenmann, David Valdecanas, Nancy Hunter, Stephen Hyde, Thomas A. Buchholz, Luka Milas, Kathryn A. Mason
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (6): 1868–1874.
https://doi.org/10.1158/1078-0432.CCR-06-2534
Published: 15 March 2007
View articletitled, 130-nm Albumin–Bound Paclitaxel Enhances Tumor Radiocurability and Therapeutic Gain
Open the PDF for 130-nm Albumin–Bound Paclitaxel Enhances Tumor Radiocurability and Therapeutic Gain in another window
Journal Articles

Targeting Toll-like Receptor 9 with CpG Oligodeoxynucleotides Enhances Tumor Response to Fractionated Radiotherapy

Free
Kathryn A. Mason, Hisanori Ariga, Robert Neal, David Valdecanas, Nancy Hunter, Arthur M. Krieg, John K. Whisnant, Luka Milas
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (1): 361–369.
https://doi.org/10.1158/1078-0432.361.11.1
Published: 21 January 2005
View articletitled, Targeting Toll-like Receptor 9 with CpG Oligodeoxynucleotides Enhances Tumor Response to Fractionated Radiotherapy
Open the PDF for Targeting Toll-like Receptor 9 with CpG Oligodeoxynucleotides Enhances Tumor Response to Fractionated Radiotherapy in another window
Journal Articles

Effect of Docetaxel on the Therapeutic Ratio of Fractionated Radiotherapy in Vivo

Free
Kathryn A. Mason, Kazushi Kishi, Nancy Hunter, Lara Buchmiller, Tetsuo Akimoto, Ritsuko Komaki, Luka Milas
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (12): 4191–4198.
Published: 01 December 1999
View articletitled, Effect of Docetaxel on the Therapeutic Ratio of Fractionated Radiotherapy in Vivo
Open the PDF for Effect of Docetaxel on the Therapeutic Ratio of Fractionated Radiotherapy in Vivo in another window